The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B
Open accessAbstract
Genome-wide DNA methylation patterns are frequently deregulated in cancer. There is considerable interest in targeting the methylation machinery in tumor cells using nucleoside analogs of cytosine, such as 5-aza-2'-deoxycytidine (5-azadC). 5-azadC exerts its antitumor effects by reactivation of aberrantly hypermethylated growth regulatory genes and cytoxicity resulting from DNA damage. We sought to better characterize the DNA damage response of tumor cells to 5-azadC and the role of DNA methyltransferases 1 and 3B (DNMT1 and DNMT3B, respectively) in modulating this process. We demonstrate that 5-azadC treatment results in growth inhibition and G(2) arrest-hallmarks of a DNA damage response. 5-azadC treatment led to formation of DNA double-strand breaks, as monitored by formation of gamma-H2AX foci and comet assay, in an ATM (ataxia-telangiectasia mutated)-dependent manner, and this damage was repaired following drug removal. Further analysis revealed activation of key strand break repair proteins including ATM, ATR (ATM-Rad3-related), checkpoint kinase 1 (CHK1), BRCA1, NBS1, and RAD51 by Western blotting and immunofluorescence. Significantly, DNMT1-deficient cells demonstrated profound defects in these responses, including complete lack of gamma-H2AX induction and blunted p53 and CHK1 activation, while DNMT3B-deficient cells generally showed mild defects. We identified a novel interaction between DNMT1 and checkpoint kinase CHK1 and showed that the defective damage response in DNMT1-deficient cells is at least in part due to altered CHK1 subcellular localization. This study therefore greatly enhances our understanding of the mechanisms underlying 5-azadC cytotoxicity and reveals novel functions for DNMT1 as a component of the cellular response to DNA damage, which may help optimize patient responses to this agent in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedSchneider‐Stock, R., Diab-Assef, M., Rohrbeck, A., Foltzer‐Jourdainne, C., Boltze, C., Hartig, R., Schönfeld, P., Roessner, A., & Gali‐Muhtasib, H. U. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074195 · Cited by 117
RetractedA simple technique for quantitation of low levels of DNA damage in individual cells
Singh, N. P., McCoy, M. T., Tice, R. R., & Schneider, E. L. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90265-0 · Cited by 10,828
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
Self-citationATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
EUKARYOTIC CYTOSINE METHYLTRANSFERASES
Goll, M. G., & Bestor, T. H. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.010904.153721 · Cited by 2,063
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Silverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
Rothkamm, K., & Löbrich, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830918100 · Cited by 1,645
Christman, J. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205699 · Cited by 1,525
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting
Kaneda, M., Okano, M., Hata, K., Sado, T., Tsujimoto, N., Li, E., & Sasaki, H. (2004) · Nature · doi:10.1038/nature02633 · Cited by 1,387
Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage
Falck, J., Coates, J., & Jackson, S. P. (2005) · Nature · doi:10.1038/nature03442 · Cited by 1,258
Chromosomal stability and the DNA double-stranded break connection
van Gent, D. C., Hoeijmakers, J. H. J., & Kanaar, R. (2001) · Nature Reviews Genetics · doi:10.1038/35056049 · Cited by 1,219
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei
Leonhardt, H., Page, A. W., Weier, H.-U., & Bestor, T. H. (1992) · Cell · doi:10.1016/0092-8674(92)90561-p · Cited by 1,055
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
Rhee, I., Bachman, K. E., Park, B. H., Jair, K.-W., Yen, R.-W. C., Schuebel, K. E., Cui, H., Feinberg, A. P., Lengauer, C., Kinzler, K. W., et al. (2002) · Nature · doi:10.1038/416552a · Cited by 1,039
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,014
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Self-citationMéndez, J., & Stillman, B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8602-8612.2000 · Cited by 915
Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21 WAF1
Chuang, L. S.-H., Ian, H.-I., Koh, T.-W., Ng, H.-H., Xu, G., & Li, B. F. L. (1997) · Science · doi:10.1126/science.277.5334.1996 · Cited by 902
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Self-citationAtaxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro
Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 829
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
Histone H2A variants H2AX and H2AZ
Redon, C., Pilch, D., Rogakou, E., Sedelnikova, O., Newrock, K., & Bonner, W. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00282-4 · Cited by 767
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731 · cited 1×
“ATM directly phosphorylates p53 at serine 15, contributing to its stabilization and increased activity as a transcription factor (12), which in turn leads to activation of a key transcriptional target of p53, the cyclindependent kinase (CDK) inhibitor p21, causing G1 arrest (58, 59).”
BackgroundJüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Nucleotide excision repair and human syndromes
de Boer, J., & Hoeijmakers, J. H. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.453 · Cited by 674
The role of double-strand break repair — insights from human genetics
O'Driscoll, M., & Jeggo, P. A. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1746 · Cited by 583
Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements
Liang, G., Chan, M. F., Tomigahara, Y., Tsai, Y. C., Gonzales, F. A., Li, E., Laird, P. W., & Jones, P. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.480-491.2002 · Cited by 569
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase
Bulavin, D. V., Higashimoto, Y., Popoff, I. J., Gaarde, W. A., Basrur, V., Potapova, O., Appella, E., & Fornace, A. J. (2001) · Nature · doi:10.1038/35075107 · Cited by 532
(1998) · PubMed · Cited by 525
Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine.
Santi, D. V., Norment, A., & Garrett, C. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6993 · Cited by 518
Daskalakis, M., Nguyen, T. T., Nguyen, C., Guldberg, P., Köhler, G., Wijermans, P., Jones, P. A., & Lübbert, M. (2002) · Blood · doi:10.1182/blood.v100.8.2957 · Cited by 514
Gore, S. D., Baylin, S., Sugar, E., Carraway, H., Miller, C. B., Carducci, M., Grever, M., Galm, O., Dauses, T., Karp, J. E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0080 · Cited by 474
Two Molecularly Distinct G2/M Checkpoints Are Induced by Ionizing Irradiation
Xu, B., Kim, S.-T., Lim, D.-S., & Kastan, M. B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1049-1059.2002 · Cited by 473
ATM-dependent phosphorylation of nibrin in response to radiation exposure
Gatei, M., Young, D., Cerosaletti, K. M., Desai-Mehta, A., Spring, K., Kozlov, S., Lavin, M. F., Gatti, R. A., Concannon, P., & Khanna, K. (2000) · Nature Genetics · doi:10.1038/75508 · Cited by 468
Furuta, T., Takemura, H., Liao, Z.-Y., Aune, G. J., Redon, C., Sedelnikova, O. A., Pilch, D. R., Rogakou, E. P., Celeste, A., Chen, H. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300198200 · Cited by 449
Bachman, K. E., Rountree, M. R., & Baylin, S. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104661200 · Cited by 438
DNA damage checkpoints in mammals
Niida, H., & Nakanishi, M. (2006) · Mutagenesis · doi:10.1093/mutage/gei063 · Cited by 432
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Bender, C. M., Pao, M. M., & Jones, P. A. (1998) · PubMed · Cited by 380
Recruitment of DNA methyltransferase I to DNA repair sites
Mortusewicz, O., Schermelleh, L., Walter, J., Cardoso, M. C., & Leonhardt, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501034102 · Cited by 380
Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., & Hornby, D. P. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00676-9 · Cited by 362
Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells
Chen, T., Hevi, S., Gay, F., Tsujimoto, N., He, T., Zhang, B., Ueda, Y., & Li, E. (2007) · Nature Genetics · doi:10.1038/ng1982 · Cited by 353
Dial 9–1–1 for DNA damage: the Rad9–Hus1–Rad1 (9–1–1) clamp complex
Parrilla-Castellar, E. R., Arlander, S. J. H., & Karnitz, L. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.032 · Cited by 342
Preferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
Rapid Activation of ATR by Ionizing Radiation Requires ATM and Mre11
Myers, J. S., & Cortez, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513265200 · Cited by 292
Karpf, A. R., & Matsui, S.-I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1961 · Cited by 276
DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2385 · Cited by 266
Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I
Barlow, C., Liyanage, M., Moens, P. B., Tarsounas, M., Nagashima, K., Brown, K., Rottinghaus, S., Jackson, S. P., Tagle, D., Ried, T., et al. (1998) · Development · doi:10.1242/dev.125.20.4007 · Cited by 263
Self-citationRecombinant ATM protein complements the cellular A-T phenotype
Ziv, Y., Bar-Shira, A., Pecker, I., Russell, P., Jorgensen, T. J., Tsarfati, I., & Shiloh, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1201319 · Cited by 240
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine)
Momparler, R. L. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.05.002 · Cited by 231
Kantarjian, H. M., O'Brien, S., Cortes, J., Giles, F. J., Faderl, S., Issa, J., Garcia‐Manero, G., Rios, M. B., Shan, J., Andreeff, M., et al. (2003) · Cancer · doi:10.1002/cncr.11543 · Cited by 227
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., & Jones, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1270-1278.2004 · Cited by 222
Kuzminov, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151260698 · Cited by 217
Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase
Jackson-Grusby, L., Laird, P. W., Magge, S. N., Moeller, B. J., & Jaenisch, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4681 · Cited by 208
Egger, G., Jeong, S., Escobar, S. G., Cortez, C. C., Li, T. W. H., Saito, Y., Yoo, C. B., Jones, P. A., & Liang, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604602103 · Cited by 207
The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease
Ehrlich, M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00201-8 · Cited by 203
Rapid PIKK-Dependent Release of Chk1 from Chromatin Promotes the DNA-Damage Checkpoint Response
Smits, V. A. J., Reaper, P. M., & Jackson, S. P. (2006) · Current Biology · doi:10.1016/j.cub.2005.11.066 · Cited by 200
Spada, F., Haemmer, A., Kuch, D., Rothbauer, U., Schermelleh, L., Kremmer, E., Carell, T., Längst, G., & Leonhardt, H. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610062 · Cited by 192
Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation
Weisenberger, D. J., Velicescu, M., Cheng, J. C., Gonzales, F. A., Liang, G., & Jones, P. A. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.62.2.1 · Cited by 183
Gius, D., Cui, H., Bradbury, C. M., Cook, J., Smart, D. K., Zhao, S., Young, L., Brandenburg, S. A., Hu, Y., Bisht, K. S., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.029 · Cited by 181
Ai, L., Tao, Q., Zhong, S., Fields, C. R., Kim, W.-J., Lee, M. W., Cui, Y., Brown, K. D., & Robertson, K. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi379 · Cited by 176
Self-citationKarpf, A. R., Moore, B. C., Ririe, T. O., & Jones, D. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09243-5 · Cited by 176
Jiang, K., Pereira, E., Maxfield, M. D., Russell, B., Goudelock, D. M., & Sánchez, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300070200 · Cited by 175
Specific Role of Chk1 Phosphorylations in Cell Survival and Checkpoint Activation
Niida, H., Katsuno, Y., Banerjee, B., Hande, M. P., & Nakanishi, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01611-06 · Cited by 166
Estève, P.-O., Chin, H. G., & Pradhan, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407729102 · Cited by 165
Adams, K. E., Medhurst, A. L., Dart, D. A., & Lakin, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209426 · Cited by 164
Ling, Y., Sankpal, U. T., Robertson, A. K., McNally, J. G., Karpova, T., & Robertson, K. D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh195 · Cited by 164
Self-citationLiu, K., Wang, Y. F., Cantemir, C., & Muller, M. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2709-2719.2003 · Cited by 160
Depletion of Chk1 Leads to Premature Activation of Cdc2-cyclin B and Mitotic Catastrophe
Niida, H., Tsuge, S., Katsuno, Y., Konishi, A., Takeda, N., & Nakanishi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505009200 · Cited by 155
5-Aza-2′-deoxycytidine Activates the p53/p21Waf1/Cip1 Pathway to Inhibit Cell Proliferation
Zhu, W., Hileman, T., Ke, Y., Wang, P., Lu, S., Duan, W., Dai, Z., Tong, T., Villalona-Calero, M. A., Plass, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311703200 · Cited by 149
Geiman, T. M., Sankpal, U. T., Robertson, A. K., Zhao, Y., Zhao, Y., & Robertson, K. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.058 · Cited by 145
Self-citationSamlowski, W. E., Leachman, S. A., Wade, M. L., Cassidy, P. B., Porter-Gill, P. A., Busby, L. T., Wheeler, R. H., Boucher, K. M., Fitzpatrick, F. A., Jones, D. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.118 · Cited by 141
Trapped in action: direct visualization of DNA methyltransferase activity in living cells
Schermelleh, L., Spada, F., Easwaran, H., Zolghadr, K., Margot, J. B., Cardoso, M. C., & Leonhardt, H. (2005) · Nature Methods · doi:10.1038/nmeth794 · Cited by 138
Oka, M., Meacham, A. M., Hamazaki, T., Rodić, N., Chang, L., & Terada, N. (2005) · Oncogene · doi:10.1038/sj.onc.1208540 · Cited by 135
Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells
Guo, G., Wang, W., & Bradley, A. (2004) · Nature · doi:10.1038/nature02653 · Cited by 135
Gollob, J., Sciambi, C. J., Peterson, B. L., Richmond, T. M., Thoreson, M., Moran, K., Dressman, H. K., Jelínek, J., & Issa, J. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0883 · Cited by 133
Geiman, T. M., Sankpal, U. T., Robertson, A. K., Chen, Y., Mazumdar, M., Heale, J. T., Schmiesing, J. A., Kim, W., Yokomori, K., Zhao, Y., et al. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh589 · Cited by 131
Self-citationMund, C., Hackanson, B. W., Stresemann, C., Lübbert, M., & Lyko, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0695 · Cited by 119
Su, N. Y., Pan, Y., Zhou, M., Harvey, R. C., Hunger, S. P., & Kilberg, M. S. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21213 · Cited by 98
DNA Methyltransferase 1 Knockdown Activates a Replication Stress Checkpoint
Unterberger, A., Andrews, S. D., Weaver, I. C. G., & Szyf, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01887-05 · Cited by 94
Issa, J. J. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0355 · Cited by 91
Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells
Kim, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh912 · Cited by 89
The absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine
Nieto, M. D., Samper, E., Fraga, M. F., de Buitrago, G. G., Esteller, M., & Serrano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207175 · Cited by 86
Robertson, A. K., Geiman, T. M., Sankpal, U. T., Hager, G. L., & Robertson, K. D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.083 · Cited by 75
Self-citationDNMT1 knockout delivers a strong blow to genome stability and cell viability
Brown, K. D., & Robertson, K. D. (2007) · Nature Genetics · doi:10.1038/ng0307-289 · Cited by 60
Self-citationIssa, J. J., Kantarjian, H. M., & Kirkpatrick, P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1726 · Cited by 55
Cell cycle effects and cellular pharmacology of 5-AZA-2?-deoxycytidine
Momparler, R. L., Samson, J., Momparler, L. F., & Rivard, G. (1984) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00269027 · Cited by 51
Up-regulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndrome
Länger, F. P., Dingemann, J., Kreipe, H. H., & Lehmann, U. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.08.004 · Cited by 43
Kantarjian, H. M., & Issa, J. J. (2005) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.05.006 · Cited by 38
The relative contribution of CHK1 and CHK2 to Adriamycin-induced checkpoint
HO, C., Siu, W. Y., Chow, J. P. H., Lau, A. W. S., Arooz, T., TONG, H., Ng, I. O., & Poon, R. Y. C. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.10.016 · Cited by 36
Demidenko, Z. N., Halicka, D. H., Kunicki, J., McCubrey, J. A., Darżynkiewicz, Z., & Blagosklonny, M. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4428 · Cited by 20
Cited by
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
Tsai, H.-C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.029 · Cited by 650
DNA Methyltransferases, DNA Damage Repair, and Cancer
Jin, B., & Robertson, K. D. (2013) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-9967-2_1 · Cited by 519
Self-citationRoles of Chk1 in cell biology and cancer therapy
Zhang, Y., & Hunter, T. (2014) · International Journal of Cancer · doi:10.1002/ijc.28226 · Cited by 462
Molecules that Promote or Enhance Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells
Feng, B., Ng, J.-H., Heng, J.-C. D., & Ng, H.-H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.005 · Cited by 381
Metadata
- Authors
- Palii, S. S., Van Emburgh, B. O., Sankpal, U. T., Brown, K. D., & Robertson, K. D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-01-01
- Volume
- 28
- Issue
- 2
- Pages
- 752-771
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2040393829
- Cited by
- 382
- References
- 101
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.